Treatment with tumour necrosis factor-inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
Arthritis & Rheumatism, 09/02/2011
Ljung L et al. – In this study of patients treated with anti–TNF therapy within the first years of Rheumatoid arthritis (RA) disease, neither treatment with, nor response to, anti–TNF therapy could be linked to any statistically significant decrease in acute coronary syndromes (ACS) risk.






